RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair

EMBO Reports

Volumn 10, Issue 11, 2009, Pages 1272-1278

  Wang, Jingxin ^a   Jacob, Naduparambil K ^a   Ladner, Katherine J ^a   Beg, Amer ^b   Perko, James D ^a   Tanner, Stephan M ^a   Liyanarachchi, Sandya ^a   Fishel, Richard ^a,c   Guttridge, Denis C ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL IMMORTALIZATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA REPAIR; EMBRYO; FIBROBLAST; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENOMIC INSTABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

3T3 CELLS; ANIMALS; CELL AGING; CELL LINE; DNA; DNA REPAIR; FIBROBLASTS; GENE DELETION; GENOMIC INSTABILITY; HYDROGEN PEROXIDE; MICE; MUTATION; NF-KAPPA B; TRANSCRIPTION FACTOR RELA; TRANSLOCATION, GENETIC;

MURINAE;

EID: 70449094653     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2009.197     Document Type: Article

References (29)

1. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J (2003) Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J 22: 4212-4222
2. Bernard D, Gosselin K, Monte D, Vercamer C, Bouali F, Pourtier A, Vandenbunder B, Abbadie C (2004) Involvement of Rel/nuclear factor-kappaB transcription factors in keratinocyte senescence. Cancer Res 64: 472-481
3. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665
4. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740
5. Chen Z et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730
6. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI (2006) The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443: 214-217
7. Courtois G, Gilmore TD (2006) Mutations in the NF-kappaB signaling pathway: Implications for human disease. Oncogene 25: 6831-6843
8. D'Andrea AD, Grompe M (2003) The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3: 23-34
9. Dajee M et al (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643
10. Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y (1999) Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 96: 2994-2999
11. German J (1993) Bloom syndrome: A Mendelian prototype of somatic mutational disease. Medicine (Baltimore) 72: 393-406
12. Gollin SM (2005) Mechanisms leading to chromosomal instability. Semin Cancer Biol 15: 33-42
13. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100 57-70
14. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18 2195-2224
15. Janssens S, Tschopp J (2006) Signals from within: The DNA-damage-induced NF-kappaB response. Cell Death Differ 13: 773-784
16. Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2: 301-310
17. Kawahara TL et al (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136: 62-74
18. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88
19. Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, Roskams T, Trautwein C, Pasparakis M (2007) Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11: 119-132
20. Maeda S, Kamata H, Luo JL, Leffert H, Karin M (2005) IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121: 977-990
21. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5: 741-747
22. Perkins ND, Gilmore TD (2006) Good cop, bad cop: The different faces of NF-kappaB. Cell Death Differ 13: 759-772
23. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85
24. Scully R, Livingston DM (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429-432
25. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM (2002) Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 158: 486-492
26. Seitz CS, Lin Q, Deng H, Khavari PA (1998) Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci USA 95: 2307-2312
27. Sherr CJ, DePinho RA (2000) Cellular senescence: Mitotic clock or culture shock? Cell 102: 407-410
28. Wu ZH, Miyamoto S (2007) Many faces of NF-kappaB signaling induced by genotoxic stress. J Mol Med 85: 1187-1202
29. Zhang JY, Tao S, Kimmel R, Khavari PA (2005) CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth control. J Cell Biol 168: 561-566